Rationale of family medicine physicians in effectively identifying patients with chronic hyperglycemia through point-of-care hemoglobin A1C screenings

被引:0
|
作者
Whitley, Heather P. [1 ,2 ]
Hanson, Courtney [3 ]
Parton, Jason M. [3 ]
Smith, Warren D. [4 ]
机构
[1] Auburn Univ, Dept Pharm Practice, Harrison Sch Pharm, Auburn, AL 36849 USA
[2] Baptist Hlth Syst, Montgomery Family Med Residency Program, 4371 Narrow Lane Rd,Suite 100, Montgomery, AL 36116 USA
[3] Univ Alabama, Inst Business Analyt, Culverhouse Coll Business, Tuscaloosa, AL USA
[4] Auburn Univ, Dept Drug Discovery & Dev, Harrison Sch Pharm, Auburn, AL 36849 USA
关键词
Diabetes; Prediabetes; Screening; A1C; Prevention; Point-of-care; IMPAIRED FASTING GLUCOSE; DIABETES-MELLITUS; BLOOD-GLUCOSE; TYPE-2; RISK; COMPLICATIONS; THERAPY;
D O I
10.1007/s40200-019-00402-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeMany patients are unknowingly living with chronic hyperglycemia, possibly due to low screening rates. We aimed to correlate detection of unidentified chronic hyperglycemia to practitioner reported rationale for conducting diabetes screening.MethodsPhysicians screened patients via a point-of-care A1C tests and recorded corresponding rationales. Elevated outcomes (A1C5.7%) were correlated to recorded rationales, frequency of repeat screenings, documented diagnoses, and therapeutic actions taken as a result of elevated A1C.ResultsNearly one-half (45%) of selected patients were unknowingly living with chronic hyperglycemia, having an average A1C of 7.92% for outcomes 6.5%. Most commonly recorded rationales were overweight status (71%), high-risk ethnicity (58%), and age>45years (48%); previously recorded A1C result of 5.7% ((2) 16.02, p<0.001) and hypertension diagnosis ((2) 10.37, p=0.0013) showed statistically significant correlation with elevated A1C outcomes. A1C results 6.5% versus 5.7-6.5% more frequently prompted repeat screenings (77% vs 20%), ICD-10 code documentation (91% vs 28%), lifestyle modification recommendations (78% vs 35%), and drug therapy initiation (78% vs 9%).ConclusionsReported rationales were largely impacted by visual inspections of age, race, and weight, and prediabetic A1C values garnered less attention compared to higher values. Utilization of POC A1C screening followed by conformational repeat testing is a practical approach to improve diagnostic rates and initiation of care for diabetes.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 50 条
  • [1] Rationale of family medicine physicians in effectively identifying patients with chronic hyperglycemia through point-of-care hemoglobin A1C screenings
    Heather P. Whitley
    Courtney Hanson
    Jason M. Parton
    Warren D. Smith
    Journal of Diabetes & Metabolic Disorders, 2019, 18 : 155 - 162
  • [2] Point-of-Care Hemoglobin A1c
    O'Brien, Matthew J.
    Sacks, David B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (14): : 1404 - 1405
  • [3] Evaluation of three hemoglobin A1c point-of-care instruments
    Criel, M.
    Jonckheere, S.
    Langlois, M.
    ACTA CLINICA BELGICA, 2015, 70 : S3 - S3
  • [4] Point-of-care hemoglobin A1c testing in postmortem examination
    Joo-Young Na
    Forensic Science, Medicine and Pathology, 2018, 14 : 322 - 326
  • [5] Assessing the Performance of Point-of-Care Hemoglobin A1c Systems
    Irvin, Ben
    Knaebel, Jennifer
    Simmons, David
    CLINICAL CHEMISTRY, 2010, 56 (08) : 1359 - 1360
  • [6] Point-of-Care Assays for Hemoglobin A1c: Is Performance Adequate?
    Little, Randie R.
    Lenters-Westra, Erna
    Rohlfing, Curt L.
    Slingerland, Robbert
    CLINICAL CHEMISTRY, 2011, 57 (09) : 1333 - 1334
  • [7] Evaluation of Three Hemoglobin A1c Point-of-Care Instruments
    Criel, Marieke
    Jonckheere, Stijn
    Langlois, Michel
    CLINICAL LABORATORY, 2016, 62 (03) : 285 - 291
  • [9] Comparison of costs of hemoglobin A1c determination by point-of-care testing (POCT) and standard hemoglobin A1c analyzer
    Wiwanitkit, V.
    ARCHIVES OF HELLENIC MEDICINE, 2010, 27 (06): : 953 - 955
  • [10] Assessing the Performance of Point-of-Care Hemoglobin A1c Systems Reply
    Lenters-Westra, Erna
    Slingerland, Robbert J.
    CLINICAL CHEMISTRY, 2010, 56 (08) : 1360 - 1361